tezspire - tezepelumab - ekko injection, solution
(Tezepelumab-Ekko)Amgen Inc
Usage: Tezspire is indicated as add-on maintenance treatment for adults and patients aged 12 and older with severe asthma, and for inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP). Not for relief of acute bronchospasm or status asthmaticus.